Literature DB >> 35101015

Retrospective analysis of bladder cancer morphology and depth of invasion under cystoscopy.

Hu Chen1, Yang Hong2, Bai Yu1, Li Ruiqian1, Li Jun1, Wu Hongyi1, Wang Ziyong1, Jiang Haiyang1, Zhang Chongjian1, Bi Ying1, Wang Qilin1.   

Abstract

BACKGROUND: The pathological diagnosis of bladder cancer workup relies on cystoscopy, however, due to sampling restriction, the depth of local invasion is often understaged.
METHODS: A total of 386 patients with bladder urothelial carcinoma underwent follow-up. The data collected included age, sex, tumor size, surgical options, histologic grade, invasive depth, lymph node metastasis, and oncological outcomes, and the patients were divided into coral-like and crumb-like groups. These data were analyzed with the chi-square test, binary logistic regression, Kaplan-Meier analysis, univariable and multivariable logistic regression and Spearman correlation test.
RESULTS: Bladder tumor morphology was moderately correlated with invasion depth (ρ = 0.492, p < 0.001; Spearman correlation), which was associated with invasion status (HR = 8.27; 95% CI 4.3-15.79, p < 0.001). Tumor morphology was not an independent factor for OS but was associated with PFS. Outer invasion depth was an independent factor that was significantly associated with inferior OS and PFS.
CONCLUSIONS: Tumor morphology (coral-like and crumb-like) under cystoscopy was related to the depth of invasion. The outer invasive depth of BC was an independent factor that was significantly associated with inferior OS and PFS.
© 2022. The Author(s).

Entities:  

Keywords:  Bladder cancer; Invasive depth; Morphology cystoscopy

Mesh:

Year:  2022        PMID: 35101015      PMCID: PMC8802509          DOI: 10.1186/s12894-022-00958-0

Source DB:  PubMed          Journal:  BMC Urol        ISSN: 1471-2490            Impact factor:   2.264


Introduction

Bladder cancer (BC) is the 10th most common cancer worldwide, and the second most common among urologic cancer, with approximately over 540,000 new cases and 200,000 deaths per year [1]. Tumors isolated to non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) [2]. The accurate local staging of bladder carcinoma is key, as it has significant prognostic implications and determines treatment options. Non-muscle-invasive bladder carcinomas (Ta–T1) are suitable for localized treatment, either TURBT or intravesical chemotherapy, while radical cystectomy with LN dissection, remains the gold standard for muscle-invasive disease (≥ T2) [3, 4]. The traditional diagnostic workup relies on cystoscopy and transurethral resection of bladder tumor (TURBT) to confirm the pathological diagnosis and muscle invasive status [3]; however, there is a discrepancy between preoperative pathological staging by cystoscopy biopsy and the postoperative pathologic staging based on surgery, with an inaccuracy rate of 23–50%, mainly due to sampling error, particularly if there is an absence of the muscle layer in the specimen, which would understage the depth of local invasion [5]. In addition, up to 25% of T1 tumors are eventually muscle invasive on subsequent TURBT, which entirely changes therapeutic management [6, 7]. Magnetic resonance imaging (MRI) can effectively cope with such limitations in local staging, and it is increasingly used for the preoperative, due to its high sensitivity to soft-tissue and ability to assess the depth of bladder wall invasion, with a recent meta-analysis reporting a high diagnostic performance in differentiating NMIBC from MIBC [8, 9]. In order to more accurately distinguish the muscular invasion state of bladder cancer, the VI-RADS score was developed in 2018. Multiparametric MRI (mpMRI), which incorporates morphological T2-weighted imaging (T2WI) alongside the functional sequences of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) imaging, has been shown to further improve the accuracy of primary and recurrent tumor detection and local staging [9, 10]. The sensitivity and specificity of a VI-RADS score of 3 or greater were 87.1% (95% CI 78–93%) and 96.5% (95% CI 93–98%), respectively [11]. Besides, 29-MHz high-resolution micro-ultrasound (mUS) technology has been suggested as a potential alternative to MRI for the detection of prostate cancer. Some research report that the measures of diagnostic accuracy indexes demonstrate an overall superiority of the mUS compared to MRI, which instead shows an important tendency in lesion upstaging compared to mUS [12]. Cystoscopy is a simple, low-cost routine preoperative operation. Compared with MRI, it can observe the tumor size, position, shape, and surface nourishing blood vessels more clearly and intuitively under direct vision. At present, there are few literature summaries and analyses of tumors with different morphologies and depths of invasion under cystoscopy. A prospective analysis correlating urologist impression at cystoscopy with final pathology. Low grade papillary tumors were accurately identified at cystoscopy 93% of the time, and when information from urine cytology was added the accuracy increased to 99% [13, 14]. We hope to assess the correlation between the morphology of the tumor and the depth of invasion, combined the morphology under cystoscopy with multiparametric mp-MRI to improve the accuracy of local T staging.

Materials and methods

Electronic medical records were reviewed to identify men treated for bladder cancer at Yunnan Cancer Hospital in China between December 2014 and May 2021. The study protocol was approved by the Yunnan Cancer Hospital Ethics Committee. Among 491 consecutive bladder cancer patients who were treated with surgery, 386 had sufficient follow-up data.

Entry criteria

Tumors were pathologically diagnosed as urothelial carcinoma; Cystoscopy was completed in our hospital before surgery; The muscle tissue was observed in postoperative pathology.

Exclusion criteria

Distant metastasis (M1); Wide base or erosion or ulcer type or urethral mass of tumor; Blurred vision during cystoscopy; Tumors smaller than 1 cm. According to Fig. 1, the 386 patients were divided into a coral-like group and a clump-like group based on the tumor inner circle radius (r) and outer branch length (l) prior to surgery under cystoscopy. Epidemiological and clinical data, including sex, age, tumor size, surgical options, histologic grade, tumor invasive depth, invasive status, lymph node metastasis status and oncological outcomes (OS and PFS), were collected. Survival analysis was performed by the Kaplan–Meier method for univariable analysis and the Cox regression method for multivariable analysis. The primary endpoints were OS and PFS, which were defined as the times from the date of pathological diagnosis to the dates of death and tumor progression, respectively. The Spearman correlation method was used to evaluate the correlation between the different morphology groups and invasive depths. Univariable (Kaplan–Meier) analysis was performed to determine any differences between the coral-like group and the clump-like group. Multivariable (Cox logistic regression) analysis was used to verify the independence of associations identified in univariable analyses and p-values.
Fig. 1

Division into two groups based on the tumor inner circle radius (r) and outer branch length (l) determined by preoperative cystoscopy

Division into two groups based on the tumor inner circle radius (r) and outer branch length (l) determined by preoperative cystoscopy

Results

The mean age (± SD) of the patients was 61.37 ± 11.9 years. The patient data and their relationships to tumor morphology are summarized in Table 1.
Table 1

Patients’ characteristics

TotalCoral-likeCrumb-likep Value
Sex (n)386264122
Male299(78)204(77)95(78)0.896
Female87(22)60(23)27(22)
Age (y)61.37 ± 11.960.09 ± 12.5764.04 ± 10.070.526
Size (n)
 < 3 cm271(70)190(72)81(66)0.265
 > 3 cm115(30)74(28)41(34)
Surgical options (n[%])
TURBT263(68)198(75)65(53) < 0.001
Partial cystectomy21(5)11(4)10(8)
Radical cystectomy102(26)55(20)47(38)
Histologic grade (n[%])
PUNLMP18(5)17(6)1(1) < 0.001
Low grade105(27)94(35)11(9)
High grade263(68)153(58)110(90)
Invasive depth
Non-muscle221(57)193(73)28(23) < 0.001
Lamina propria87(23)44(17)43(35)
Inner half33(8)14(5)19(16)
Outer half16(4)8(3)8(6)
Perivesical29(8)5(2)24(20)
Invasive status
No221(57)193(73)28(23) < 0.001
Yes165(43)71(27)94(77)
Muscle-invasive status
No307(80)236(89)71(58) < 0.001
Yes79(20)28(11)51(41)
Lymph node metastasis
No374(97)261(98)113(93)0.001
Yes12(3)3(1)9(7)
Recurrence (n[%])
No350(91)236(89)114(93)0.203
Yes36(9)28(11)8(7)
Vital status (n[%])
Alive371(96)256(97)115(94)0.2
Dead15(4)8(3)7(6)
Patients’ characteristics The chi-square test showed that the coral-like group and clump-like group had significant differences in surgical methods, histologic grade, depth of invasion, and lymph node metastasis. The Spearman correlation test showed that bladder tumor morphology was moderately correlated with invasion depth (ρ = 0.492, p < 0.001) and invasion status (ρ = 0.467, p < 0.001), whereas muscle-invasive status (ρ = 0.36, p < 0.001), surgical methods (ρ = 0.213, p < 0.001), histologic grade (ρ = 0.321, p < 0.001), and lymph node metastasis (ρ = 0.167, p = 0.001) were weakly correlated, and the remaining variables were not correlated (Table 2).
Table 2

Correlation of bladder tumor morphology

VariablesBladder tumor morphologyp Value
Spearman correlation
Sex (n[%]) − 0.0070.897
Age (y)0.140.006
Size (n[%])0.0570.267
Surgical type (n[%])0.213 < 0.001
Histologic grade (n[%])0.321 < 0.001
Invasive depth0.492 < 0.001
Invasive status0.467 < 0.001
Muscle-invasive status0.36 < 0.001
Lymph node metastasis0.1670.001
Recurrence (n[%]) − 0.0650.204
Vital status (n[%])0.0650.202
Correlation of bladder tumor morphology We used binary logistic regression to analyze the hazard ratios between invasive status and various factors, and the results suggest that tumor morphology was associated with invasive status (HR = 8.27; 95% CI 4.3–15.79, p < 0.001), partial cystectomy (HR = 10.65; 95% CI 2.74–41.37, p = 0.001) and radical cystectomy (HR = 15.75; 95% CI 7.93–33.98, p < 0.001), as shown in Table 3.
Table 3

Logistic regression of invasive status and other factors

VariablesInvasive status
HR95% CIp
Tumor morphology
Coral-like8.274.3–15.79 < 0.001
Crumb-like
Size
 < 3 cm1.300.66–2.590.447
 > 3 cm
Surgical type
TURBTReference
Partial cystectomy10.652.74–41.370.001
Radical cystectomy15.757.93–33.98 < 0.001
Histologic grade
PUNLMPReference
Low grade0.690.08–6.380.692
High grade5.730.69–46.960.104
Logistic regression of invasive status and other factors Among the 386 patients, 371 survived (median follow-up duration 45 months, interquartile range 29–60 months). In total, 350 patients did not experience recurrence (median follow-up duration 43 months, interquartile range 22–58 months). Disease progression occurred in 36 patients, 20 of whom survived. Kaplan–Meier analysis produced the following results: different bladder tumor morphologies (coral-like and clump-like) were not associated with OS, and tumor morphology was not associated with OS (log-rank p = 0.206) or PFS (log-rank p = 0.250), as shown in Fig. 2.
Fig. 2

Follow up of OS and PFS

Follow up of OS and PFS In univariable analyses, tumor morphology was not associated with OS (HR = 1.9; 95% CI 0.69–5.26, p < 0.214). However, coral-like morphology was associated with better PFS (HR = 0.63; 95% CI 029–1.39, p = 0.225). In terms of the surgical type, radical cystectomy was significantly associated with inferior OS (HR = 16.49; 95% CI 3.69–73.69, p < 0.001) compared to TURBT and not associated with PFS (HR = 1.48; 95% CI 0.73–2.99, p = 0.274). Outer invasive depth was significantly associated with both inferior OS (HR = 78.49; 95% CI 9.16–672.83, p < 0.001) and PFS (HR = 4.57; 95% CI 1.7–12.33, p < 0.002). Perivesical invasive depth was associated with inferior OS (HR = 34.27; 95% CI 3.83–306.93, p = 0.002) but was not associated with PFS (HR = 1.93; 95% CI 0.65–5.7, p < 0.235). Lymph node metastasis status was significantly associated with inferior OS (HR = 13.46; 95% CI 4.27–42.45, p < 0.001) and PFS (HR = 5.25; 95% CI 1.86–14.88, p = 0.005). We performed multivariate analysis, which revealed that tumor morphology was not a significant independent factor for OS (p = 0.337) but was associated with PFS (p = 0.026). Outer invasive depth was an independent factor that was significantly associated with both inferior OS (HR = 53.74; 95% CI 3.24–892.21, p = 0.005) and PFS (HR = 7.73; 95% CI 2.06–29.06, p < 0.002). In the multivariate analysis, lymph node metastasis status remained significant for OS (HR = 6.36; 95% CI 1.33–30.44, p = 0.021) and PFS (HR = 8.07; 95% CI 1.9–34.27, p = 0.005), as indicated in the NCCN and EAU guidelines. However, age, sex, tumor size, surgical type and histologic grade were not significant for OS and PFS in the multivariable analysis (Table 4).
Table 4

Cox regression model for OS and PFS

Variables0SPFS
UnivariableMultivariableUnivariableMultivariable
HR95% CIpHR95% CIpHR95% CIpHR95% CIp
Tumor morphology
Coral-like1.90.69–5.260.2140.560.17–1.840.3370.630.29–1.390.2550.340.13–0.880.026
Crumb-like
Size
 < 3 cm2.630.95–7.250.0620.680.23–2.040.4931.290.65–2.550.4630.840.38–1.840.658
 > 3 cm
Surgical type
TURBTReferenceReferenceReferenceReference
Partial cystectomy6.440.58–71.070.1281.220.81–18.280.8871.140.27–4.860.8580.560.11–2.950.496
Radical cystectomy16.493.69–73.69 < 0.0013.050.47–19.970.2501.480.73–2.990.2740.610.21–1.790.365
Histologic grade
Punlmp0.000.000.590.08–4.330.6030.560.07–4.390.584
Low grade0.1760.02–1.340.0931.190.1–14.00.8930.640.28–1.460.2860.630.25–1.610.337
High gradeReferenceReferenceReferenceReference
Invasive depth
Non-muscleReferenceReferenceReferenceReference
Lamina propria5.300.48–58.420.7133.420.19–59.730.3990.740.27–1.980.5440.870.27–2.790.811
Inner half20.122.09–193.50.00915.250.85–274.960.0651.430.48–4.220.5212.650.66–10.690.170
Outer half78.499.16–672.83 < 0.00153.743.24–892.210.0054.571.7–12.330.0037.732.06–29.060.002
Perivesical34.273.83–306.930.00210.630.48–234.390.1341.930.65–5.70.2352.140.38–12.050.389
Lymph nodes metastic
No13.64.27–42.45 < 0.0016.361.33–30.440.0215.251.86–14.880.0028.071.9–34.270.005
Yes
Cox regression model for OS and PFS

Discussion

The diagnosis of bladder cancer requires cystoscopy to obtain the tumor tissue for pathological diagnosis as the gold standard. The pathological results can provide clear information to distinguish between benign and malignant disease and different cancer types. However, it is difficult to obtain samples from the base of the tumor, resulting in inconsistent invasive depth of the preoperative and postoperative pathological diagnoses. The depth of infiltration of the preoperative bladder tissue is often understaged [5]. Preoperatively judging whether the tumor is noninvasive and invades the lamina propria can help the surgeon adjust the depth and breadth of the resection during the operation, maximize the resection to avoid recurrence of the tumor, and improve the prognosis. Second, whether there is muscle invasion directly determines the surgical type as TURBT or radical cystectomy. At present, judging whether there is muscle infiltration is usually determined by MRI. If MRI can be combined with the morphology of the tumor under cystoscopy to improve the accuracy of determining muscle infiltration status, a more reasonable surgical strategy can be chosen to benefit patients. The relationship between tumor morphology and infiltration was analyzed through Cox regression. The risk of coral-like tumor invasion was 8.27 times that of crumb-like tumor invasion. Therefore, tumor morphology has important value for determining whether infiltration is present, and this information helps in the preoperative staging of tumors and in the selection of surgical type to benefit patients. Univariate Cox regression indicated that morphology was mainly related to infiltration and had a relationship with the prognostic factors for OS and PFS. The results of multivariate analysis indicated that patients with crumb-like tumors had a longer PFS, which does not match our hypothesis. This may be because there are fewer TURBT options for patients with crumb-like tumors, radical resection or partial resection are other options, and crumb-like tumors are generally subjectively cut deeper during resection. These factors may be related to longer PFS. Second, infiltration reaching the deep muscle layer is a threshold and is associated with worse OS and PFS. In the next step, prospective experiments will be carried out to compare the accuracy, sensitivity, specificity and positive/negative predictive values separately of preoperative cystoscopy with MRI and mUS on the depth of infiltration. Besides, MRI and mUS will combine to establish a predictive model for preoperative local staging of bladder cancer, hoping to improve the accuracy of judging the status and depth of invasion, which will help in the selection of surgical procedures and the prognosis of patients.

Conclusions

Tumor morphology (coral-like and crumb-like) under cystoscopy was related to the depth of invasion. The outer invasive depth of BC was an independent factor that was significantly associated with inferior OS and PFS. Additional file 1. Coral-like morphology of bladder cancer under cystoscope. Additional file 2. Crumb-like morphology of bladder cancer under cystoscope.
  13 in total

1.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

2.  Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion.

Authors:  Huanjun Wang; Cheng Luo; Fan Zhang; Jian Guan; Shurong Li; Haohua Yao; Junxing Chen; Junhang Luo; Lingwu Chen; Yan Guo
Journal:  Radiology       Date:  2019-04-23       Impact factor: 11.105

3.  Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis.

Authors:  Niket Gandhi; Satheesh Krishna; Christopher M Booth; Rodney H Breau; Trevor A Flood; Scott C Morgan; Nicola Schieda; Jean-Paul Salameh; Trevor A McGrath; Matthew D F McInnes
Journal:  BJU Int       Date:  2018-06-03       Impact factor: 5.588

4.  Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer.

Authors:  Francis Thomas; Aidan P Noon; Naomi Rubin; John R Goepel; James W F Catto
Journal:  Eur Urol       Date:  2012-09-05       Impact factor: 20.096

Review 5.  MRI of Bladder Cancer: Local and Nodal Staging.

Authors:  Iztok Caglic; Valeria Panebianco; Hebert A Vargas; Vlad Bura; Sungmin Woo; Martina Pecoraro; Stefano Cipollari; Evis Sala; Tristan Barrett
Journal:  J Magn Reson Imaging       Date:  2020-02-29       Impact factor: 4.813

6.  Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.

Authors:  J Alfred Witjes; Thierry Lebret; Eva M Compérat; Nigel C Cowan; Maria De Santis; Harman Maxim Bruins; Virginia Hernández; Estefania Linares Espinós; James Dunn; Mathieu Rouanne; Yann Neuzillet; Erik Veskimäe; Antoine G van der Heijden; Georgios Gakis; Maria J Ribal
Journal:  Eur Urol       Date:  2016-06-30       Impact factor: 20.096

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

8.  Long-term Outcomes from Re-resection for High-risk Non-muscle-invasive Bladder Cancer: A Potential to Rationalize Use.

Authors:  Patrick C Gordon; Francis Thomas; Aidan P Noon; Derek J Rosario; James W F Catto
Journal:  Eur Urol Focus       Date:  2017-10-28

9.  Bladder Cancer.

Authors:  Andrew T Lenis; Patrick M Lec; Karim Chamie
Journal:  JAMA       Date:  2020-11-17       Impact factor: 56.272

10.  Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?

Authors:  Huyen T Nguyen; Amir Mortazavi; Kamal S Pohar; Debra L Zynger; Lai Wei; Zarine K Shah; Guang Jia; Michael V Knopp
Journal:  Bladder Cancer       Date:  2017-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.